Funding Information - Office of Global Health and Health Disparities

File
This is a preview of the Data Table. Only the first three rows are displayed.
Expiration Date FOA Title FOA Number/URL Release Date Research Category
7/15/2022 Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) PAR-20-164 4/3/2020 Health Disparities
9/8/2022 Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity NOT-NS-20-024 5/5/2020 Bilateral Program
none Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) NOT-MD-21-016 2/23/2021 Health Disparities
12/12/2023 Emerging Global Leader Award (K43 Independent Clinical Trial Required) PAR-21-251 9/8/2021 Global Health
12/12/2023 Emerging Global Leader Award (K43 Independent Clinical Trial Not Required) PAR-21-252 9/8/2021 Global Health
12/12/2023 Global Brain and Nervous System Disorders Research Across the Lifespan (R21) PAR-21-319 9/13/2021 Global Health
12/12/2023 Global Brain and Nervous System Disorders Research Across the Lifespan (R01, PAR-21-311) PAR-21-311 9/13/2021 Global Health
7/14/2023 Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) PAR-21-230 5/24/2021 Global Health
2/1/2024 Notice of Special Interest (NOSI): Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) NOT-OD-22-032 12/2/2021 Health Disparities
7/16/2024 Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) PAR-22-104 3/11/2022 Global Health
8/11/2022 Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs)and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional) PAR-22-132 3/30/2022 Global Health
Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 06/2024